Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model

被引:33
作者
Wu, Jianjun [1 ]
Yu, Wenbo [1 ]
Chen, Yan [1 ]
Su, Yaru [1 ]
Ding, Zhengtong [1 ]
Ren, Huimin [1 ]
Jiang, Yuping [1 ]
Wang, Jian [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China
基金
上海市自然科学基金;
关键词
Parkinson's disease; Glial cell line-derived neurotrophic factor; Lentivirus; Gene therapy; Bone marrow stromal cells; Lactacystin; MARROW STROMAL CELLS; RETRACTED ARTICLE. SEE; ALPHA-SYNUCLEIN; NEUROTROPHIC FACTOR; DISEASE; IMPAIRMENT; PATHOLOGY; DELIVERY; FORM;
D O I
10.1007/s11064-009-0086-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential value of glial cell line-derived neurotrophic factor (GDNF) in treating Parkinson's disease (PD) remains controversial. In order to evaluate the therapeutic effect of GDNF-engineered bone marrow stromal cells (BMSCs) in parkinsonian rat model, GDNF-BMSCs and LacZ-BMSCs were transplanted into striatum and followed by Lactacystin lesioning at median forebrain bundles 1 week later. We observed that the intrastriatal transplantation of GDNF-BMSCs could significantly rescue the dopaminergic neurons from lactacystin-induced neurotoxicity with regard to behavioral recovery, tyrosine hydroxylase level in nigra and striatum, and striatal dopamine level. We interpret the outcomes that intrastriatal transplantation of GDNF-BMSCs might be beneficial in the treatment of PD.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 35 条
[11]   Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors [J].
García, R ;
Aguiar, J ;
Alberti, E ;
de la Cuétara, K ;
Pavón, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (03) :753-754
[12]   Functional recovery in parkinsonian monkeys treated with GDNF [J].
Gash, DM ;
Zhang, ZM ;
Ovadia, A ;
Cass, WA ;
Yi, A ;
Simmerman, L ;
Russell, D ;
Martin, D ;
Lapchak, PA ;
Collins, F ;
Hoffer, BJ ;
Gerhardt, GA .
NATURE, 1996, 380 (6571) :252-255
[13]   Localized striatal delivery of GDNF as a treatment for Parkinson disease [J].
Kirik, D ;
Georgievska, B ;
Björklund, A .
NATURE NEUROSCIENCE, 2004, 7 (02) :105-110
[14]   Long-term rAAV-mediated gene transfer of GDNF in the rat parkinson's model:: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system [J].
Kirik, D ;
Rosenblad, C ;
Björkland, A ;
Mandel, RJ .
JOURNAL OF NEUROSCIENCE, 2000, 20 (12) :4686-4700
[15]   Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease [J].
Kordower, Jeffrey H. ;
Chu, Yaping ;
Hauser, Robert A. ;
Freeman, Thomas B. ;
Olanow, C. Warren .
NATURE MEDICINE, 2008, 14 (05) :504-506
[16]   Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys [J].
Kordower, Jeffrey H. ;
Kanaan, Nicholas M. ;
Chu, Yaping ;
Babu, Rangasamy Suresh ;
Stansell, James, III ;
Terpstra, Brian T. ;
Sortwell, Caryl E. ;
Steece-Collier, Kathy ;
Collier, Timothy J. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :264-268
[17]   Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease [J].
Lo Bianco, C ;
Déglon, N ;
Pralong, W ;
Aebischer, P .
NEUROBIOLOGY OF DISEASE, 2004, 17 (02) :283-289
[18]   Lack of nigrostriatal pathology in a rat model of proteasome inhibition [J].
Manning-Bog, Amy B. ;
Reaney, Stephen H. ;
Chou, Vivian P. ;
Johnston, Louisa C. ;
McCormack, Alison L. ;
Johnston, Jennifer ;
Langston, J. William ;
Di Monte, Donato A. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :256-260
[19]   Proteasome inhibitor-induced model of Parkinson's disease [J].
McNaught, Kevin St. P. ;
Olanow, C. Warren .
ANNALS OF NEUROLOGY, 2006, 60 (02) :243-247
[20]   Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures [J].
McNaught, KS ;
Mytilineou, C ;
JnoBaptiste, R ;
Yabut, J ;
Shashidharan, P ;
Jenner, P ;
Olanow, CW .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) :301-306